Ausgabe 4/2017
Including the Topical Section: Lymph Node Dissection in Urological Cancers
Inhalt (22 Artikel)
Lymph node dissection in urological cancers: one topic, many controversies
Avinash Nehra, R. Jeffrey Karnes, Giorgio Gandaglia, Alberto Briganti
The rationale and the role of lymph node dissection in renal cell carcinoma
Umberto Capitanio, Bradley C. Leibovich
PET imaging for lymph node dissection in prostate cancer
Elena Incerti, Paola Mapelli, Luigi Gianolli, Maria Picchio
Update on histopathological evaluation of lymphadenectomy specimens from prostate cancer patients
Alessandro Conti, Matteo Santoni, Luciano Burattini, Marina Scarpelli, Roberta Mazzucchelli, Andrea B. Galosi, Liang Cheng, Antonio Lopez-Beltran, Alberto Briganti, Francesco Montorsi, Rodolfo Montironi
Lymph node dissection in bladder cancer: Where do we stand?
Cory M. Hugen, Siamak Daneshmand
Contemporary role of lymph node dissection at the time of radical nephroureterectomy for upper tract urothelial carcinoma
Thomas Seisen, Shahrokh F. Shariat, Olivier Cussenot, Benoit Peyronnet, Raphaële Renard-Penna, Pierre Colin, Morgan Rouprêt
Neural supply of the male urethral sphincter: comprehensive anatomical review and implications for continence recovery after radical prostatectomy
Thomas Bessede, Prasanna Sooriakumaran, Atsushi Takenaka, Ash Tewari
Cytoreductive radical prostatectomy in metastatic prostate cancer: Does it really make sense?
Romain Mathieu, Stephan M. Korn, Karim Bensalah, Gero Kramer, Shahrokh F. Shariat
Optimal screening interval for men with low baseline prostate-specific antigen levels (≤1.0 ng/mL) in a prostate cancer screening program
Satoko Urata, Yasuhide Kitagawa, Satoko Matsuyama, Renato Naito, Kenji Yasuda, Atsushi Mizokami, Mikio Namiki
Current impact of age and comorbidity assessment on prostate cancer treatment choice and over/undertreatment risk
Pierre Lunardi, Guillaume Ploussard, Pascale Grosclaude, Mathieu Roumiguié, Michel Soulié, Jean Baptiste Beauval, Bernard Malavaud
Analysis of active surveillance uptake for low-risk localized prostate cancer in Canada: a Canadian multi-institutional study
Narhari Timilshina, Veronique Ouellet, Shabbir M. H. Alibhai, Anne-Marie Mes-Masson, Nathalie Delvoye, Darrel Drachenberg, Antonio Finelli, Marie-Paule Jammal, Pierre Karakiewicz, Hélène Lapointe, Jean-Baptiste Lattouf, Kenny Lynch, Jean-Benoît Paradis, Paula Sitarik, Alan So, Fred Saad
Can robot-assisted laparoscopic radical prostatectomy (RALP) be performed very soon after biopsy?
Jung Ki Jo, Jong Jin Oh, Sangchul Lee, Seong Jin Jeong, Sung Kyu Hong, Seok-Soo Byun, Sang Eun Lee
Genetic variants in RNA-induced silencing complex genes and prostate cancer
Z. Nikolić, D. Savić Pavićević, N. Vučić, S. Cerović, V. Vukotić, G. Brajušković
Redefining the implications of nasogastric tube placement following radical cystectomy in the alvimopan era
Vignesh T. Packiam, Vijay A. Agrawal, Joseph J. Pariser, Andrew J. Cohen, Charles U. Nottingham, Shane M. Pearce, Norm D. Smith, Gary D. Steinberg
Impact of tumor histology and grade on treatment success of percutaneous renal cryoablation
Alp Tuna Beksac, Gerant Rivera-Sanfeliz, Catherine A. Dufour, Unwanaobong Nseyo, Zachary Hamilton, Sean W. Berquist, Abd-elRahman Hassan, Omer A. Raheem, Song Wang, Robert W. Wake, Robert E. Gold, Ithaar H. Derweesh
Second-line treatment for metastatic clear cell renal cell cancer: experts’ consensus algorithms
C. Rothermundt, J. von Rappard, T. Eisen, B. Escudier, V. Grünwald, J. Larkin, D. McDermott, J. Oldenburg, C. Porta, B. Rini, M. Schmidinger, C. N. Sternberg, P. M. Putora
Partial nephrectomy versus ablative therapy for the treatment of renal tumors in an imperative setting
Jean-Alexandre Long, Jean-Christophe Bernhard, Pierre Bigot, Cecilia Lanchon, Philippe Paparel, Nathalie Rioux-Leclercq, Laurence Albiges, Thomas Bodin, François-Xavier Nouhaud, Romain Boissier, Pierre Gimel, Arnaud Méjean, Alexandra Masson-Lecomte, Nicolas Grenier, Francois Cornelis, Yohann Grassano, Vincent Comat, Quentin Come Le Clerc, Jérome Rigaud, Laurent Salomon, Jean-Luc Descotes, Christian Sengel, Morgan Roupret, Gregory Verhoest, Idir Ouzaid, Valentin Arnoux, Karim Bensalah
Surgical control and margin status after robotic and open cystectomy in high-risk cases: Caution or equivalence?
Pranav Sharma, Kamran Zargar-Shoshtari, Michael A. Poch, Julio M. Pow-Sang, Wade J. Sexton, Philippe E. Spiess, Scott M. Gilbert
Does lymph node dissection during nephroureterectomy affect oncological outcomes in upper tract urothelial carcinoma patients without suspicious lymph node metastasis on preoperative imaging studies?
Sangjun Yoo, Dalsan You, In Gab Jeong, Bumsik Hong, Jun Hyuk Hong, Hanjong Ahn, Choung-Soo Kim
Complications associated with ureterorenoscopy (URS) related to treatment of urolithiasis: the Clinical Research Office of Endourological Society URS Global study
B. K. Somani, G. Giusti, Y. Sun, P. J. Osther, M. Frank, M. De Sio, B. Turna, J. de la Rosette
Ales Vidlar, Vladimir Student Jr., Jitka Vostalova, Emilie Fromentin, Marc Roller, Vilím Simanek, Vladimir Student: Cranberry fruit powder (Flowens™) improves lower urinary tract symptoms in men: a double-blind, randomized, placebo-controlled study. World Journal of Urology: March 2016, Volume 34, Issue 3, pp 419–424
Ram Niwas Yadav, Apul Goel, Bimalesh Purkait, Ashok Kumar Gupta
Re: Impact of preoperative hemoglobin and CRP levels on cancer-specific survival in patients undergoing radical cystectomy for transitional cell carcinoma of the bladder: results of a single-center study
Ozgu Aydogdu, Ibrahim Halil Bozkurt, Tarik Yonguc